TetratherixASX:TTX -1.45%15 PB Ratio is 12.64 as of Jun. 26, 2026. GuruFocus rates ASX:TTX with a GF Score™ of 15/100. Among 1,232 Biotechnology companies, Tetratherix ranks worse than 89.69% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), Tetratherix's share price is A$6.12. Tetratherix's Book Value per Share for the quarter that ended in Dec. 2025 was A$0.48. Hence, Tetratherix's PB Ratio of today is 12.64.
The historical rank and industry rank for Tetratherix's PB Ratio or its related term are showing as below:
ASX:TTX'
s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 12.64
Current: 12.64
During the past 3 years, Tetratherix's highest PB Ratio was 12.64. The lowest was 0.00. And the median was 0.00.
ASX:TTX's PB Ratio is ranked worse than 89.69% of 1232
companies
in the Biotechnology industry
Industry Median: 2.8
vs ASX:TTX: 12.64
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Tetratherix PB Ratio Related Terms
Tetratherix PB Ratio Historical Data
* Premium members only.
The historical data trend for Tetratherix's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Tetratherix's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tetratherix PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tetratherix's PB Ratio distribution charts can be found below:
* The bar in red indicates where Tetratherix's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Tetratherix's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Tetratherix (ASX:TTX) has a PB Ratio of 12.64 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Tetratherix and its competitors. According to the industry distribution chart, Tetratherix ranks #1105 out of 1232 companies in the Biotechnology industry, placing it in the top 89.7%.
Is Tetratherix's PB Ratio too high?
Tetratherix's current PB Ratio is 12.64. The Biotechnology industry median PB Ratio is 2.80. Tetratherix's value of 12.64 is 351.4% above this industry median. Based on the distribution chart, Tetratherix ranks #1105 out of 1232 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Tetratherix has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Tetratherix's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Tetratherix ranks #1105 out of 1232 companies for PB Ratio. This places Tetratherix in the lower half of its industry. The industry median PB Ratio is 2.80. Tetratherix's value of 12.64 is 351.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.80, based on 1,232 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tetratherix's current PB Ratio of 12.64 is 351.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Tetratherix and its competitors. For the Biotechnology industry, the median PB Ratio is 2.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tetratherix's current PB Ratio is 12.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tetratherix stock overvalued right now?
Tetratherix (ASX:TTX) has a current PB Ratio of 12.64. The current PB Ratio is 12.64 and 351.4% above the Biotechnology industry median of 2.80. Tetratherix's overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Tetratherix (ASX:TTX), the current PB Ratio is 12.64 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Tetratherix Ltd is a biomedical company that has developed an biomaterial platform called Tetramatrix, a proprietary fluid matrix that induces minimal foreign body reaction. The principal activities include development programs in the areas of regenerative medicine and commercialising medical device technology across multiple applications including Bone Regeneration, Tissue Spacing and Tissue Healing.
15GF Score
Get the complete analysis for ASX:TTX
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:TTX has been successfully added to your 